contact usfaqupdatesindexconversations
missionlibrarycategoriesupdates

JPMorgan Begins Coverage of Alkami Technology with Positive Outlook

June 26, 2025 - 01:06

JPMorgan Begins Coverage of Alkami Technology with Positive Outlook

Alkami Technology, Inc. (NASDAQ: ALKT) has recently caught the attention of analysts as it faces scrutiny from short sellers, being labeled as one of the ten worst aggressive growth stocks to buy. On June 18, JPMorgan analyst Ella Smith initiated coverage of Alkami's stock, assigning it an “Overweight” rating along with a revised price target of $40, down from a previous estimate of $45.

The analyst emphasized the company’s impressive gross margin expansion, a key indicator of financial health and operational efficiency. This development suggests that Alkami is making strides in improving profitability, which could attract investor interest despite the challenges posed by short selling sentiment.

Investors will be keen to see how Alkami navigates the current market landscape and whether the company's growth strategies will resonate positively in the coming quarters. With JPMorgan's endorsement, there is a sense of cautious optimism surrounding Alkami’s potential for future growth.


MORE NEWS

Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above Views

September 30, 2026 - 21:59

Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above Views

Micron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...

Space Force Turns to Laser Systems to Shield Launch Sites from Drone Threats

September 30, 2026 - 01:50

Space Force Turns to Laser Systems to Shield Launch Sites from Drone Threats

The U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...

DIU Seeks Investors in Counter-Unmanned Systems Technology

September 29, 2026 - 04:58

DIU Seeks Investors in Counter-Unmanned Systems Technology

The Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...

Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing Agreement

September 28, 2026 - 02:02

Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing Agreement

Novo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...

read all news
contact usfaqupdatesindexeditor's choice

Copyright © 2026 Tech Warps.com

Founded by: Adeline Taylor

conversationsmissionlibrarycategoriesupdates
cookiesprivacyusage